SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-09-001455
Filing Date
2009-10-14
Accepted
2009-10-14 17:30:17
Documents
7
Period of Report
2009-07-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT generex_10k-073109.htm 10-K 9584842
2 RESTATED CERTIFICATE OF INCORPORATION OF GENEREX BIOTECHNOLOGY CORPORATION ex3i.htm EX-3.(I) 21572
3 SUBSIDIARIES OF THE REGISTRANT ex21.htm EX-21 11038
4 CONSENT OF MSCM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex23-1.htm EX-23.1 3252
5 CERTIFICATION ex31-1.htm EX-31.1 21760
6 CERTIFICATION ex31-2.htm EX-31.2 22172
7 CERTIFICATION ex32.htm EX-32 6959
  Complete submission text file 0001437749-09-001455.txt   9673046
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 000-25169 | Film No.: 091119946
SIC: 2834 Pharmaceutical Preparations